These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34057117)

  • 1. Profile of anterior gradient 3 (AGR3) mRNA expression and serum levels in benign and malignant breast tumors.
    Prihantono P; Rahardjo W; Syamsu SA; Smaradhania N
    Breast Dis; 2021; 40(S1):S39-S43. PubMed ID: 34057117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection.
    Garczyk S; von Stillfried S; Antonopoulos W; Hartmann A; Schrauder MG; Fasching PA; Anzeneder T; Tannapfel A; Ergönenc Y; Knüchel R; Rose M; Dahl E
    PLoS One; 2015; 10(4):e0122106. PubMed ID: 25875093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anterior Gradient 3 Promotes Breast Cancer Development and Chemotherapy Response.
    Xu Q; Shao Y; Zhang J; Zhang H; Zhao Y; Liu X; Guo Z; Chong W; Gu F; Ma Y
    Cancer Res Treat; 2020 Jan; 52(1):218-245. PubMed ID: 31291711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models.
    Gray TA; MacLaine NJ; Michie CO; Bouchalova P; Murray E; Howie J; Hrstka R; Maslon MM; Nenutil R; Vojtesek B; Langdon S; Hayward L; Gourley C; Hupp TR
    J Immunol Methods; 2012 Apr; 378(1-2):20-32. PubMed ID: 22361111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer.
    King ER; Tung CS; Tsang YT; Zu Z; Lok GT; Deavers MT; Malpica A; Wolf JK; Lu KH; Birrer MJ; Mok SC; Gershenson DM; Wong KK
    Am J Surg Pathol; 2011 Jun; 35(6):904-12. PubMed ID: 21451362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of TP53 and AGR3 to distinguish ovarian high-grade serous carcinoma from low-grade serous carcinoma.
    Qiu C; Wang Y; Wang X; Zhang Q; Li Y; Xu Y; Jin C; Bu H; Zheng W; Yang X; Lu N; Kong B
    Int J Oncol; 2018 Jun; 52(6):2041-2050. PubMed ID: 29620196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of anterior gradient protein 3 in intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
    Brychtova V; Zampachova V; Hrstka R; Fabian P; Novak J; Hermanova M; Vojtesek B
    Exp Mol Pathol; 2014 Jun; 96(3):375-81. PubMed ID: 24747240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Impact of AGR3 Protein Expression in Breast Cancer: A Systematic Review and Meta-analysis.
    Moraes CL; Mendonça CR; Melo NCE; Tacon FSA; Junior JPM; Amaral WND
    Rev Bras Ginecol Obstet; 2023 Oct; 45(10):e609-e619. PubMed ID: 37944928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DDX43 mRNA expression and protein levels in relation to clinicopathological profile of breast cancer.
    Amer NN; Khairat R; Hammad AM; Kamel MM
    PLoS One; 2023; 18(5):e0284455. PubMed ID: 37200388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anterior gradient protein 3 is associated with less aggressive tumors and better outcome of breast cancer patients.
    Obacz J; Brychtova V; Podhorec J; Fabian P; Dobes P; Vojtesek B; Hrstka R
    Onco Targets Ther; 2015; 8():1523-32. PubMed ID: 26170690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.
    El-Attar NI; Gaefar HA
    Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-expression of Anterior Gradient 3 Is Associated With Tumor Progression and Poor Survival in Gastric Cancer.
    Lee WS; Park SY; Park YL; Joo YE
    In Vivo; 2023; 37(1):483-489. PubMed ID: 36593009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AGR3 promotes the stemness of colorectal cancer via modulating Wnt/β-catenin signalling.
    Chi J; Zhang H; Hu J; Song Y; Li J; Wang L; Wang Z
    Cell Signal; 2020 Jan; 65():109419. PubMed ID: 31526829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AGR3 promotes estrogen receptor-positive breast cancer cell proliferation in an estrogen-dependent manner.
    Jian L; Xie J; Guo S; Yu H; Chen R; Tao K; Yang C; Li K; Liu S
    Oncol Lett; 2020 Aug; 20(2):1441-1451. PubMed ID: 32724387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of human anterior gradient protein 3.
    Nguyen VD; Biterova E; Salin M; Wierenga RK; Ruddock LW
    Acta Crystallogr F Struct Biol Commun; 2018 Jul; 74(Pt 7):425-430. PubMed ID: 29969106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of tumor cell-specific mRNA in the peripheral blood of patients with breast cancer—evaluation of several markers with real-time reverse transcription-PCR.
    Andergassen U; Hofmann S; Kölbl AC; Schindlbeck C; Neugebauer J; Hutter S; Engelstädter V; Ilmer M; Friese K; Jeschke U
    Int J Mol Sci; 2013 Jan; 14(1):1093-104. PubMed ID: 23299436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival.
    Pelkonen M; Luostari K; Tengström M; Ahonen H; Berdel B; Kataja V; Soini Y; Kosma VM; Mannermaa A
    BMC Cancer; 2015 May; 15():431. PubMed ID: 26014348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular detection of peripheral blood breast cancer mRNA transcripts as a surrogate biomarker for circulating tumor cells.
    Lasa A; Garcia A; Alonso C; Millet P; Cornet M; Ramón y Cajal T; Baiget M; Barnadas A
    PLoS One; 2013; 8(9):e74079. PubMed ID: 24058517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular AGR3 regulates breast cancer cells migration via Src signaling.
    Obacz J; Sommerova L; Sicari D; Durech M; Avril T; Iuliano F; Pastorekova S; Hrstka R; Chevet E; Delom F; Fessart D
    Oncol Lett; 2019 Nov; 18(5):4449-4456. PubMed ID: 31611954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin Induced Protein (PIP) is a potential biomarker for early stage and malignant breast cancer.
    Gangadharan A; Nyirenda T; Patel K; Jaimes-Delgadillo N; Coletta D; Tanaka T; Walland AC; Jameel Z; Vedantam S; Tang S; Mannion C; Lee GY; Goy A; Pecora A; Suh KS
    Breast; 2018 Jun; 39():101-109. PubMed ID: 29656222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.